Novartis Signs Antibody-Drug Conjugates Deal With OBI Pharma
Novartis signed a collaboration and license agreement with OBI Pharma for antibody-drug conjugates.
Novartis signed a collaboration and license agreement with OBI Pharma for antibody-drug conjugates.